Structural determinants for recognition and translocation by the anandamide transporter
Open Access
- 11 May 1999
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 96 (10) , 5802-5807
- https://doi.org/10.1073/pnas.96.10.5802
Abstract
The biological actions of anandamide (arachidonylethanolamide), an endogenous cannabinoid lipid, are terminated by a two-step inactivation process consisting of carrier-mediated uptake and intracellular hydrolysis. Anandamide uptake in neurons and astrocytes is mediated by a high-affinity, Na+-independent transporter that is selectively inhibited by N-(4-hydroxyphenyl)-arachidonamide (AM404). In the present study, we examined the structural determinants governing recognition and translocation of substrates by the anandamide transporter constitutively expressed in a human astrocytoma cell line. Competition experiments with a select group of analogs suggest that substrate recognition by the transporter is favored by a polar nonionizable head group of defined stereochemical configuration containing a hydroxyl moiety at its distal end. The secondary carboxamide group interacts favorably with the transporter, but may be replaced with either a tertiary amide or an ester, suggesting that it may serve as hydrogen acceptor. Thus, 2-arachidonylglycerol, a putative endogenous cannabinoid ester, also may serve as a substrate for the transporter. Substrate recognition requires the presence of at least one cis double bond situated at the middle of the fatty acid carbon chain, indicating a preference for ligands whose hydrophobic tail can adopt a bent U-shaped conformation. On the other hand, uptake experiments with radioactively labeled substrates show that no fewer than four cis nonconjugated double bonds are required for optimal translocation across the cell membrane, suggesting that substrates are transported in a folded hairpin conformation. These results outline the general structural requisites for anandamide transport and may assist in the development of selective inhibitors with potential clinical applications.Keywords
This publication has 30 references indexed in Scilit:
- Endogenous Cannabinoid SignalingNeurobiology of Disease, 1998
- Exploration of Biologically Relevant Conformations of Anandamide, 2-Arachidonylglycerol, and Their Analogues Using Conformational MemoriesJournal of Medicinal Chemistry, 1998
- Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amidesNature, 1996
- Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brainBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Formation and inactivation of endogenous cannabinoid anandamide in central neuronsNature, 1994
- (R)-Methanandamide: A Chiral Novel Anandamide Possessing Higher Potency and Metabolic StabilityJournal of Medicinal Chemistry, 1994
- Conformational analysis of arachidonic and related fatty acids using molecular dynamics simulationsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Neurobiology of marijuana abuseTrends in Pharmacological Sciences, 1992
- Treatment of Human Spasticity with Δ9‐TetrahydrocannabinolThe Journal of Clinical Pharmacology, 1981